Hans Lilja
Hans Lilja
Member and Attending, Memorial Sloan Kettering Cancer Center, New York, NY, U.S.A.
Verified email at mskcc.org
TitleCited byYear
Screening and prostate-cancer mortality in a randomized European study
FH Schr÷der, J Hugosson, MJ Roobol, TLJ Tammela, S Ciatto, V Nelen, ...
New England Journal of Medicine 360 (13), 1320-1328, 2009
44212009
Prostate-cancer mortality at 11 years of follow-up
FH Schr÷der, J Hugosson, MJ Roobol, TLJ Tammela, S Ciatto, V Nelen, ...
New England Journal of Medicine 366 (11), 981-990, 2012
14332012
Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin
H Lilja, A Christensson, U DahlÚn, MT Matikainen, O Nilsson, ...
Clinical chemistry 37 (9), 1618-1625, 1991
11701991
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
FH Schr÷der, J Hugosson, MJ Roobol, TLJ Tammela, M Zappa, V Nelen, ...
The Lancet 384 (9959), 2027-2035, 2014
11122014
Mortality results from the G÷teborg randomised population-based prostate-cancer screening trial
J Hugosson, S Carlsson, G Aus, S Bergdahl, A Khatami, P Lodding, ...
The lancet oncology 11 (8), 725-732, 2010
10532010
A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein.
H Lilja
The Journal of clinical investigation 76 (5), 1899-1903, 1985
8871985
Serum Prostate Specific Antigen Complexed to α1-Antichymotrypsin as an Indicator of Prostate Cancer
A Christensson, T Bj÷rk, O Nilsson, U DahlÚn, MT Matikainen, ...
The Journal of urology 150 (1), 100-105, 1993
8731993
Differential exoprotease activities confer tumor-specific serum peptidome patterns
J Villanueva, DR Shaffer, J Philip, CA Chaparro, H Erdjument-Bromage, ...
The Journal of clinical investigation 116 (1), 271-284, 2006
8502006
Enzymatic activity of prostate‐specific antigen and its reactions with extracellular serine proteinase inhibitors
A CHRISTENSSON, CB LAURELL, H Lilja
European journal of biochemistry 194 (3), 755-763, 1990
7821990
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring
H Lilja, D Ulmert, AJ Vickers
Nature Reviews Cancer 8 (4), 268-278, 2008
7392008
Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer
DC Danila, G Heller, GA Gignac, R Gonzalez-Espinoza, A Anand, ...
Clinical cancer research 13 (23), 7053-7058, 2007
6432007
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers
CM Sturgeon, MJ Duffy, UH Stenman, H Lilja, N Brunner, DW Chan, ...
Clinical chemistry 54 (12), e11-e79, 2008
627*2008
Molecular cloning of human prostate specific antigen cDNA
┼ Lundwall, H Lilja
FEBS letters 214 (2), 317-322, 1987
4871987
Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen.
H Lilja, J Oldbring, G Rannevik, CB Laurell
The Journal of clinical investigation 80 (2), 281-285, 1987
4631987
Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition
AJ Stephenson, MW Kattan, JA Eastham, ZA Dotan, FJ Bianco Jr, H Lilja, ...
J Clin Oncol 24 (24), 3973-8, 2006
4562006
Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era
RT McCormack, TJ Wang, HG Rittenhouse, RL Wolfert, JA Finlay, H Lilja, ...
Urology 45 (5), 729-744, 1995
4211995
Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios
JE Oesterling, SJ Jacobsen, GG Klee, K Petterson, T Piironen, ...
The Journal of urology 154 (3), 1090-1095, 1995
3991995
Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer
DR Shaffer, MA Leversha, DC Danila, O Lin, R Gonzalez-Espinoza, B Gu, ...
Clinical cancer research 13 (7), 2023-2029, 2007
3592007
The role of SPINK1 in ETS rearrangement-negative prostate cancers
SA Tomlins, DR Rhodes, J Yu, S Varambally, R Mehra, S Perner, ...
Cancer cell 13 (6), 519-528, 2008
3302008
Semenogelin, the predominant protein in human semen. Primary structure and identification of closely related proteins in the male accessory sex glands and on the spermatozoa.
H Lilja, PA Abrahamsson, A Lundwall
Journal of Biological Chemistry 264 (3), 1894-1900, 1989
3221989
The system can't perform the operation now. Try again later.
Articles 1–20